Waddell & Associates’s Insulet PODD Stock Holding History

Waddell & Associates’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Buy	2,417 +931	+63%	+$155K	0.02%	337
2026 Q1	$312K	Buy	+1,486	New	+$373K	0.02%	330

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Waddell & Associates's PODD Position: Q2 2026 in Review

Waddell & Associates increased its Insulet (PODD) stake by 63% in Q2 2026, buying an estimated $155K and bringing the position to 2,417 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #337.

Waddell & Associates first reported a position in PODD in Q1 2026 and has held it in 2 quarters since. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

Waddell & Associates held 2,417 shares of Insulet worth $368K as of Q2 2026.
Waddell & Associates bought 931 Insulet shares in Q2 2026, an estimated $155K.
Insulet made up 0.02% of Waddell & Associates's portfolio in Q2 2026, its #337 holding.
Waddell & Associates first reported a position in Insulet in Q1 2026 and has held it in 2 quarters since.
731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.